1SUG image
Deposition Date 2004-03-26
Release Date 2004-09-07
Last Version Date 2023-08-23
Entry Detail
PDB ID:
1SUG
Keywords:
Title:
1.95 A structure of apo protein tyrosine phosphatase 1B
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.20
R-Value Work:
0.18
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Protein-tyrosine phosphatase, non-receptor type 1
Gene (Uniprot):PTPN1
Chain IDs:A
Chain Length:321
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B.
Acta Crystallogr.,Sect.D 60 1527 1534 (2004)
PMID: 15333922 DOI: 10.1107/S0907444904015094

Abstact

Protein tyrosine phosphatase 1B (PTP1B) plays a key role as a negative regulator of insulin and leptin signalling and is therefore considered to be an important molecular target for the treatment of type 2 diabetes and obesity. Detailed structural information about the structure of PTP1B, including the conformation and flexibility of active-site residues as well as the water-molecule network, is a key issue in understanding ligand binding and enzyme kinetics and in structure-based drug design. A 1.95 A apo PTP1B structure has been obtained, showing four highly coordinated water molecules in the active-site pocket of the enzyme; hence, the active site is highly solvated in the apo state. Three of the water molecules are located at positions that approximately correspond to the positions of the phosphate O atoms of the natural substrate phosphotyrosine and form a similar network of hydrogen bonds. The active-site WPD-loop was found to be in the closed conformation, in contrast to previous observations of wild-type PTPs in the apo state, in which the WPD-loop is open. The closed conformation is stabilized by a network of hydrogen bonds. These results provide new insights into and understanding of the active site of PTP1B and form a novel basis for structure-based inhibitor design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures